Jones Financial Companies’s LAVA Therapeutics LVTX Stock Holding History

Jones Financial Companies’s Portfolio LVTX Stock Details LVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-400	Closed	-$636	–	4522
2025 Q3	$636	Hold	400	–	–	﹤0.01%	3990
2025 Q2	$528	Buy	+400	New	+$509	﹤0.01%	3797

Jones Financial Companies's LVTX Position: Q4 2025 in Review

Jones Financial Companies sold out of LAVA Therapeutics (LVTX) in Q4 2025, closing a stake of 400 shares — an estimated $636 sold.

Jones Financial Companies first reported a position in LVTX in Q2 2025 and held it in 2 quarters. The position peaked at $636 in Q3 2025. 0 funds tracked by Wall St. Rank hold LVTX as of Q4 2025.

Jones Financial Companies reported no remaining LAVA Therapeutics position as of Q4 2025 after selling out during the quarter.
Jones Financial Companies sold 400 LAVA Therapeutics shares in Q4 2025, an estimated $636.
Jones Financial Companies first reported a position in LAVA Therapeutics in Q2 2025 and held it in 2 quarters.
Jones Financial Companies's LAVA Therapeutics position peaked at $636 in Q3 2025.
0 funds tracked by Wall St. Rank held LAVA Therapeutics as of Q4 2025.

Based on Jones Financial Companies's 13F filing for Q4 2025, filed 17 Feb 2026.